FINANCIAL STATEMENTS PERFORMANCE SUMMARY BUSINESS DESCRIPTION BUSINESS REVIEW GOVERNANCE OTHER INFORMATION 212833 DIAGEO REPORT P128-145 5 9 08 10:14 Page 135 DIAGEO | ANNUAL REPORT 2008 23 TRADE AND OTHER PAYABLES 2008 2007 Current Non-current Current Non-current liabilities liabilities liabilities liabilities million million million million Trade payables 664 558 Tax and social security excluding income tax 311 1 293 1 Other payables 485 33 464 37 Accruals and deferred income 683 573 2,143 34 1,888 38 24 PROVISIONS Restructuring Thalidomide Onerous and Vacant Trust contracts integration properties Other Total million million million million million million At 30 June 2007 143 87 9 24 71 334 Exchange differences 1 45 Provisions charged during the year 77 3 36 116 Provisions used during the year 10 14 4 7 27 62 Provisions reversed during the year 4 2 5 11 Transfers 5 5 Unwinding of discounts 8 5 1 14 At 30 June 2008 141 79 78 19 84 401 Included in current liabilities 710 6 64372 Included in non-current liabilities 134 69 72 13 41 329 141 79 78 19 84 401 Provisions by their nature are subject to uncertainties with respect to the timing and outcomes of future events.
a The Thalidomide Trust provision was established in the year ended 30 June 2005 in respect of the discounted value of the groups commitment to the Thalidomide Trust, and will be utilised over the period of the commitment up to 2037. b Included in onerous contracts provisions is 73 million 2007 80 million in respect of the discounted value of an onerous supply contract arising on the acquisition of the Seagram spirits and wine businesses on 21 December 2001.
This provision will be utilised over the 10-year duration of the contract.
c In the year ended 30 June 2008, the provision for restructuring and integration costs was increased by 70 million for the restructuring of the Irish brewing operations.
d The vacant property provision is based on the estimated discounted rental shortfall over the terms of the leases up to 2031. e Other provisions include 33 million 2007 31 million in respect of employee deferred compensation plans and 7 million 2007 9 million arising from commitments in respect of businesses sold which will predominantly be utilised within the next few years.
